Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Rheumatology (Oxford, England)|June 16, 2023
Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritisAnton Öberg Sysojev, Saedis Saevarsdottir, Lina-Marcela Diaz-Gallo, et al.
Annals of the Rheumatic Diseases|April 7, 2007
QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countriesTuulikki Sokka, Hannu Kautiainen, Sergio Toloza, et al.
Biology of Sex Differences|August 10, 2017
Long-term follow-up in primary Sjögren's syndrome reveals differences in clinical presentation between female and male patientsJorge I Ramírez Sepúlveda, Marika Kvarnström, Per Eriksson, et al.
Annals of the Rheumatic Diseases|August 21, 2017
Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative projectLouise K Mercer, Anne C Regierer, Xavier Mariette, et al.
Rheumatology (Oxford, England)|December 18, 2024
A high polygenic risk score is associated with SSA/SSB antibody positivity and early onset in primary Sjögren's diseaseCecilia Fugmann, Sarah Reid, Pascal Pucholt, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 16, 2024
Unraveling the Genetics of Shared Clinical and Serological Manifestations in Patients With Systemic Inflammatory Autoimmune DiseasesMatteo Bianchi, Sergey V Kozyrev, Antonella Notarnicola, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 22, 2022
Strong Association of Combined Genetic Deficiencies in the Classical Complement Pathway With Risk of Systemic Lupus Erythematosus and Primary Sjögren's SyndromeChristian Lundtoft, Christopher Sjöwall, Solbritt Rantapää-Dahlqvist, et al.
Rheumatology (Oxford, England)|September 5, 2020
Genetic and clinical basis for two distinct subtypes of primary Sjögren's syndromeGuðný Ella Thorlacius, Lina Hultin-Rosenberg, Johanna K Sandling, et al.
BMJ (Clinical Research Ed.)|December 3, 2020
Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trialMerete Lund Hetland, Espen A Haavardsholm, Anna Rudin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 22, 2022
Complement C4 Copy Number Variation is Linked to SSA/Ro and SSB/La Autoantibodies in Systemic Inflammatory Autoimmune DiseasesChristian Lundtoft, Pascal Pucholt, Myriam Martin, et al.
Pageof 7